Ryan Specialty (RYAN) Competitors

$54.19
+0.03 (+0.06%)
(As of 05/17/2024 ET)

RYAN vs. EQH, ERIE, BRP, BRO, WTW, AJG, DOC, FNF, BIP, and KEY

Should you be buying Ryan Specialty stock or one of its competitors? The main competitors of Ryan Specialty include Equitable (EQH), Erie Indemnity (ERIE), The Baldwin Insurance Group (BRP), Brown & Brown (BRO), Willis Towers Watson Public (WTW), Arthur J. Gallagher & Co. (AJG), Healthpeak Properties (DOC), Fidelity National Financial (FNF), Brookfield Infrastructure Partners (BIP), and KeyCorp (KEY). These companies are all part of the "finance" sector.

Ryan Specialty vs.

Ryan Specialty (NYSE:RYAN) and Equitable (NYSE:EQH) are both large-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, community ranking, dividends, analyst recommendations, profitability, earnings, valuation and risk.

Ryan Specialty has a net margin of 9.15% compared to Equitable's net margin of 0.00%. Ryan Specialty's return on equity of 45.87% beat Equitable's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty9.15% 45.87% 6.28%
Equitable N/A N/A N/A

Equitable received 234 more outperform votes than Ryan Specialty when rated by MarketBeat users. Likewise, 60.47% of users gave Equitable an outperform vote while only 37.70% of users gave Ryan Specialty an outperform vote.

CompanyUnderperformOutperform
Ryan SpecialtyOutperform Votes
23
37.70%
Underperform Votes
38
62.30%
EquitableOutperform Votes
257
60.47%
Underperform Votes
168
39.53%

In the previous week, Equitable had 2 more articles in the media than Ryan Specialty. MarketBeat recorded 7 mentions for Equitable and 5 mentions for Ryan Specialty. Equitable's average media sentiment score of 1.07 beat Ryan Specialty's score of 1.06 indicating that Equitable is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Equitable
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ryan Specialty presently has a consensus price target of $54.25, indicating a potential upside of 0.11%. Equitable has a consensus price target of $40.10, indicating a potential downside of 1.55%. Given Ryan Specialty's higher possible upside, equities analysts plainly believe Ryan Specialty is more favorable than Equitable.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
1 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.22
Equitable
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

Equitable has higher revenue and earnings than Ryan Specialty. Equitable is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$2.08B6.79$61.04M$0.53102.25
Equitable$10.53B1.26$1.05B$3.2312.61

Ryan Specialty has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Equitable has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500.

84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 92.7% of Equitable shares are owned by institutional investors. 11.1% of Ryan Specialty shares are owned by company insiders. Comparatively, 1.1% of Equitable shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Ryan Specialty pays an annual dividend of $0.44 per share and has a dividend yield of 0.8%. Equitable pays an annual dividend of $0.88 per share and has a dividend yield of 2.2%. Ryan Specialty pays out 83.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Equitable pays out 27.2% of its earnings in the form of a dividend. Equitable is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Equitable beats Ryan Specialty on 13 of the 20 factors compared between the two stocks.

Get Ryan Specialty News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYAN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYAN vs. The Competition

MetricRyan SpecialtyInsurance agents, brokers, & service IndustryFinance SectorNYSE Exchange
Market Cap$14.11B$17.96B$10.07B$18.13B
Dividend Yield0.81%2.75%5.84%3.44%
P/E Ratio102.2523.7437.0422.66
Price / Sales6.7928.90207.8410.60
Price / Cash21.6626.5916.6819.24
Price / Book14.498.193.326.00
Net Income$61.04M$953.69M$1.01B$966.17M
7 Day Performance0.89%1.80%1.72%1.85%
1 Month Performance5.80%6.15%4.59%6.59%
1 Year Performance22.27%7.09%19.56%23.69%

Ryan Specialty Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EQH
Equitable
4.4829 of 5 stars
$40.23
-0.2%
$40.10
-0.3%
+63.4%$13.08B$10.40B12.468,500
ERIE
Erie Indemnity
2.3792 of 5 stars
$394.17
-2.1%
N/A+73.7%$20.62B$3.27B42.576,556Short Interest ↓
BRP
The Baldwin Insurance Group
3.1788 of 5 stars
$30.48
+1.4%
$33.40
+9.6%
+49.6%$3.56B$1.22B-33.133,927Analyst Forecast
News Coverage
BRO
Brown & Brown
4.7992 of 5 stars
$88.44
+1.1%
$87.30
-1.3%
+35.6%$25.23B$4.26B27.219,705Short Interest ↓
Analyst Revision
WTW
Willis Towers Watson Public
4.3049 of 5 stars
$253.89
+0.1%
$295.54
+16.4%
+13.1%$25.96B$9.48B25.4748,000
AJG
Arthur J. Gallagher & Co.
4.7657 of 5 stars
$250.78
+0.5%
$255.77
+2.0%
+20.1%$54.80B$10.07B50.7752,000Analyst Forecast
Insider Selling
Short Interest ↓
DOC
Healthpeak Properties
4.2189 of 5 stars
$19.82
+1.3%
$18.50
-6.7%
+42.3%$13.95B$2.18B56.63193Analyst Forecast
Short Interest ↑
News Coverage
FNF
Fidelity National Financial
4.8976 of 5 stars
$51.96
+1.1%
$55.80
+7.4%
+48.7%$14.05B$12.35B17.091,200Short Interest ↓
BIP
Brookfield Infrastructure Partners
4.4821 of 5 stars
$29.95
-1.9%
$38.20
+27.5%
-17.0%$13.82B$18.90B96.6152,000
KEY
KeyCorp
4.6157 of 5 stars
$15.11
+1.5%
$15.71
+3.9%
+53.2%$14.25B$10.40B19.1317,333

Related Companies and Tools

This page (NYSE:RYAN) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners